Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Divestments (2018 - 2019)

Ironwood Pharmaceuticals (IRWD) has disclosed Divestments for 3 consecutive years, with -$4.2 million as the latest value for Q1 2019.

  • Quarterly Divestments changed N/A to -$4.2 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was -$4.2 million through Dec 2019, down 133.83% year-over-year, with the annual reading at -$4.2 million for FY2019, 48.94% up from the prior year.
  • Divestments hit -$4.2 million in Q1 2019 for Ironwood Pharmaceuticals, down from -$3.0 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of -$3.0 million in Q4 2018 to a low of -$4.2 million in Q1 2019.